| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 5-diphosphoinositol pentakisphosphate 1-kinase activity | 1.96e-05 | 2 | 89 | 2 | GO:0033857 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 2.18e-05 | 37 | 89 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 6.65e-05 | 18 | 89 | 3 | GO:0022851 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 7.88e-05 | 19 | 89 | 3 | GO:0004890 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 3-kinase activity | 1.17e-04 | 4 | 89 | 2 | GO:0052724 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 1-kinase activity | 1.17e-04 | 4 | 89 | 2 | GO:0052723 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 1.24e-04 | 22 | 89 | 3 | GO:0016917 | |
| GeneOntologyMolecularFunction | diphosphoinositol pentakisphosphate kinase activity | 1.95e-04 | 5 | 89 | 2 | GO:0000829 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate kinase activity | 1.95e-04 | 5 | 89 | 2 | GO:0000828 | |
| GeneOntologyMolecularFunction | inositol-1,3,4,5,6-pentakisphosphate kinase activity | 1.95e-04 | 5 | 89 | 2 | GO:0000827 | |
| GeneOntologyMolecularFunction | inositol hexakisphosphate 5-kinase activity | 1.95e-04 | 5 | 89 | 2 | GO:0000832 | |
| GeneOntologyMolecularFunction | helicase activity | 7.08e-04 | 158 | 89 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | inositol phosphate kinase activity | 1.05e-03 | 11 | 89 | 2 | GO:0180030 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.13e-03 | 262 | 89 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 1.44e-03 | 50 | 89 | 3 | GO:0099095 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 1.69e-03 | 114 | 89 | 4 | GO:0004843 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.10e-03 | 57 | 89 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | K63-linked deubiquitinase activity | 2.26e-03 | 16 | 89 | 2 | GO:0061578 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 2.30e-03 | 124 | 89 | 4 | GO:0101005 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 2.44e-03 | 60 | 89 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.51e-03 | 127 | 89 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | quinone binding | 2.56e-03 | 17 | 89 | 2 | GO:0048038 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 2.56e-03 | 17 | 89 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 2.56e-03 | 17 | 89 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 3.06e-03 | 65 | 89 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 3.06e-03 | 65 | 89 | 3 | GO:0022824 | |
| GeneOntologyBiologicalProcess | cellular response to histamine | 2.59e-06 | 7 | 88 | 3 | GO:0071420 | |
| GeneOntologyBiologicalProcess | response to histamine | 1.61e-05 | 12 | 88 | 3 | GO:0034776 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 6.65e-05 | 19 | 88 | 3 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 9.08e-05 | 21 | 88 | 3 | GO:1902710 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 2.07e-04 | 201 | 88 | 6 | GO:0099634 | |
| MousePheno | abnormal social investigation | 2.35e-06 | 171 | 71 | 8 | MP:0001360 | |
| MousePheno | decreased dentate gyrus size | 6.90e-06 | 8 | 71 | 3 | MP:0012460 | |
| MousePheno | abnormal learning/memory/conditioning | GABRB1 GABRB2 GABRB3 DOCK3 RALGAPA1 ARID1B KLHL1 PTPRA UBE3A NACC1 CNIH2 SRC PRKCB ZC3H12B CHD8 CNKSR2 ADCY3 MYBPC3 | 3.32e-05 | 1239 | 71 | 18 | MP:0002063 |
| MousePheno | abnormal cognition | GABRB1 GABRB2 GABRB3 DOCK3 RALGAPA1 ARID1B KLHL1 PTPRA UBE3A NACC1 CNIH2 SRC PRKCB ZC3H12B CHD8 CNKSR2 ADCY3 MYBPC3 | 3.58e-05 | 1246 | 71 | 18 | MP:0014114 |
| MousePheno | abnormal response to social novelty | 1.09e-04 | 49 | 71 | 4 | MP:0020395 | |
| Domain | GABAAb_rcpt | 9.76e-08 | 3 | 87 | 3 | IPR002289 | |
| Domain | BRK | 1.93e-06 | 6 | 87 | 3 | SM00592 | |
| Domain | BRK_domain | 1.93e-06 | 6 | 87 | 3 | IPR006576 | |
| Domain | BRK | 1.93e-06 | 6 | 87 | 3 | PF07533 | |
| Domain | Chromo_domain | 4.35e-06 | 24 | 87 | 4 | IPR023780 | |
| Domain | Chromo | 6.07e-06 | 26 | 87 | 4 | PF00385 | |
| Domain | CHROMO_1 | 8.26e-06 | 28 | 87 | 4 | PS00598 | |
| Domain | CHROMO_2 | 8.26e-06 | 28 | 87 | 4 | PS50013 | |
| Domain | SNF2_N | 1.43e-05 | 32 | 87 | 4 | IPR000330 | |
| Domain | Chromodomain-like | 1.43e-05 | 32 | 87 | 4 | IPR016197 | |
| Domain | SNF2_N | 1.43e-05 | 32 | 87 | 4 | PF00176 | |
| Domain | Chromo/shadow_dom | 1.62e-05 | 33 | 87 | 4 | IPR000953 | |
| Domain | CHROMO | 1.62e-05 | 33 | 87 | 4 | SM00298 | |
| Domain | K_chnl_volt-dep_EAG | 2.14e-05 | 2 | 87 | 2 | IPR003949 | |
| Domain | Tyr_Pase_rcpt_a/e-type | 2.14e-05 | 2 | 87 | 2 | IPR016336 | |
| Domain | ARM-type_fold | 2.84e-05 | 339 | 87 | 9 | IPR016024 | |
| Domain | Helicase_C | 1.43e-04 | 107 | 87 | 5 | PF00271 | |
| Domain | HELICc | 1.43e-04 | 107 | 87 | 5 | SM00490 | |
| Domain | Helicase_C | 1.49e-04 | 108 | 87 | 5 | IPR001650 | |
| Domain | HELICASE_CTER | 1.56e-04 | 109 | 87 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.56e-04 | 109 | 87 | 5 | PS51192 | |
| Domain | DEXDc | 1.56e-04 | 109 | 87 | 5 | SM00487 | |
| Domain | GABAA/Glycine_rcpt | 1.62e-04 | 23 | 87 | 3 | IPR006028 | |
| Domain | Helicase_ATP-bd | 1.63e-04 | 110 | 87 | 5 | IPR014001 | |
| Domain | Acid_Pase_AS | 3.18e-04 | 6 | 87 | 2 | IPR033379 | |
| Domain | - | 4.13e-04 | 207 | 87 | 6 | 1.25.40.10 | |
| Domain | HIS_ACID_PHOSPHAT_2 | 4.44e-04 | 7 | 87 | 2 | PS00778 | |
| Domain | HIS_ACID_PHOSPHAT_1 | 4.44e-04 | 7 | 87 | 2 | PS00616 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 5.74e-04 | 35 | 87 | 3 | IPR002464 | |
| Domain | His_Pase_clade-2 | 5.90e-04 | 8 | 87 | 2 | IPR000560 | |
| Domain | His_Phos_2 | 5.90e-04 | 8 | 87 | 2 | PF00328 | |
| Domain | DEAH_ATP_HELICASE | 7.32e-04 | 38 | 87 | 3 | PS00690 | |
| Domain | TPR-like_helical_dom | 7.69e-04 | 233 | 87 | 6 | IPR011990 | |
| Domain | PAS_9 | 9.42e-04 | 10 | 87 | 2 | PF13426 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.20e-03 | 45 | 87 | 3 | IPR018000 | |
| Domain | Neur_chan_memb | 1.28e-03 | 46 | 87 | 3 | PF02932 | |
| Domain | Neur_chan_LBD | 1.37e-03 | 47 | 87 | 3 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 1.37e-03 | 47 | 87 | 3 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 1.37e-03 | 47 | 87 | 3 | IPR006029 | |
| Domain | - | 1.37e-03 | 47 | 87 | 3 | 2.70.170.10 | |
| Domain | Neur_channel | 1.37e-03 | 47 | 87 | 3 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.37e-03 | 47 | 87 | 3 | IPR006202 | |
| Domain | ARM-like | 1.64e-03 | 270 | 87 | 6 | IPR011989 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 1.88e-03 | 14 | 87 | 2 | IPR003938 | |
| Domain | TPR | 3.11e-03 | 129 | 87 | 4 | SM00028 | |
| Domain | TPR_repeat | 3.47e-03 | 133 | 87 | 4 | IPR019734 | |
| Domain | His_PPase_superfam | 3.86e-03 | 20 | 87 | 2 | IPR029033 | |
| Domain | - | 3.86e-03 | 20 | 87 | 2 | 3.40.50.1240 | |
| Pubmed | GABAA receptor beta 1, beta 2, and beta 3 subunits: comparisons in DBA/2J and C57BL/6J mice. | 1.62e-08 | 3 | 89 | 3 | 7893750 | |
| Pubmed | Expression and distribution of GABAA receptor subtypes in human alcoholic cerebral cortex. | 1.62e-08 | 3 | 89 | 3 | 11085308 | |
| Pubmed | GABAA receptor beta subunit mRNA expression in the human alcoholic brain. | 1.62e-08 | 3 | 89 | 3 | 15337300 | |
| Pubmed | 1.62e-08 | 3 | 89 | 3 | 1282920 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 1321150 | ||
| Pubmed | 1.61e-07 | 5 | 89 | 3 | 15198677 | ||
| Pubmed | Evolution of GABA(A) receptor diversity in the human genome. | 3.22e-07 | 6 | 89 | 3 | 10023064 | |
| Pubmed | The GABAA Receptor β Subunit Is Required for Inhibitory Transmission. | 3.22e-07 | 6 | 89 | 3 | 29706582 | |
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 5.63e-07 | 7 | 89 | 3 | 20843900 | |
| Pubmed | 8.99e-07 | 8 | 89 | 3 | 11528422 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.65e-06 | 608 | 89 | 10 | 36089195 | |
| Pubmed | 5.78e-06 | 14 | 89 | 3 | 22768092 | ||
| Pubmed | CUL3 KIF13B KIFBP UBE3A NACC1 PABPC3 PKP4 SYNE2 SRC PRKCB CHD8 CNKSR2 | 6.36e-06 | 963 | 89 | 12 | 28671696 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 32276354 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 28656243 | ||
| Pubmed | GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies. | 6.48e-06 | 2 | 89 | 2 | 21735059 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 7537734 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 18981179 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 26950270 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 23486367 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 30615487 | ||
| Pubmed | Multiple modes for conferring surface expression of homomeric beta1 GABAA receptors. | 6.48e-06 | 2 | 89 | 2 | 18650446 | |
| Pubmed | PKC and PTPα participate in Src activation by 1α,25OH2 vitamin D3 in C2C12 skeletal muscle cells. | 6.48e-06 | 2 | 89 | 2 | 21459125 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 20158519 | ||
| Pubmed | Lifelong restructuring of 3D genome architecture in cerebellar granule cells. | 6.48e-06 | 2 | 89 | 2 | 37676945 | |
| Pubmed | Functional distinction of human EAG1 and EAG2 potassium channels. | 6.48e-06 | 2 | 89 | 2 | 11943152 | |
| Pubmed | In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy. | 6.48e-06 | 2 | 89 | 2 | 10532952 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 12196556 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 22989919 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 15522235 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 17702752 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 15615769 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 25241062 | ||
| Pubmed | Roles of surface residues of intracellular domains of heag potassium channels. | 6.48e-06 | 2 | 89 | 2 | 19172261 | |
| Pubmed | Protein tyrosine phosphatases ε and α perform nonredundant roles in osteoclasts. | 6.48e-06 | 2 | 89 | 2 | 24694598 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 7691597 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 16870705 | ||
| Pubmed | Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms. | 6.48e-06 | 2 | 89 | 2 | 13679430 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 14503638 | ||
| Pubmed | A phosphotyrosine displacement mechanism for activation of Src by PTPalpha. | 6.48e-06 | 2 | 89 | 2 | 10698938 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 28126903 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 28867767 | ||
| Pubmed | Src kinase regulation by phosphorylation and dephosphorylation. | 6.48e-06 | 2 | 89 | 2 | 15845350 | |
| Pubmed | Direct binding of GABAA receptor β2 and β3 subunits to gephyrin. | 6.48e-06 | 2 | 89 | 2 | 23205938 | |
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 17690096 | ||
| Pubmed | 6.48e-06 | 2 | 89 | 2 | 11834728 | ||
| Pubmed | 7.38e-06 | 104 | 89 | 5 | 9205841 | ||
| Pubmed | 1.29e-05 | 18 | 89 | 3 | 19078961 | ||
| Pubmed | 1.29e-05 | 18 | 89 | 3 | 18985723 | ||
| Pubmed | CREBRF KIF13B DES STAG1 PABPC3 CHD5 SYNE2 DDX42 PHF14 APOB CAGE1 CHD6 PTBP1 PPIP5K2 | 1.73e-05 | 1442 | 89 | 14 | 35575683 | |
| Pubmed | 1.79e-05 | 730 | 89 | 10 | 34857952 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.87e-05 | 582 | 89 | 9 | 20467437 | |
| Pubmed | Transgenic overexpression of furin increases epileptic susceptibility. | 1.94e-05 | 3 | 89 | 2 | 30333479 | |
| Pubmed | Molecular basis of titin exon exclusion by RBM20 and the novel titin splice regulator PTB4. | 1.94e-05 | 3 | 89 | 2 | 29518215 | |
| Pubmed | RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3. | 1.94e-05 | 3 | 89 | 2 | 30468920 | |
| Pubmed | PPIP5K2 and PCSK1 are Candidate Genetic Contributors to Familial Keratoconus. | 1.94e-05 | 3 | 89 | 2 | 31852976 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 26343497 | ||
| Pubmed | Protrudin modulates seizure activity through GABAA receptor regulation. | 1.94e-05 | 3 | 89 | 2 | 31772151 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 22865929 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 20808828 | ||
| Pubmed | N-Glycosylation of GABAA receptor subunits is altered in Schizophrenia. | 1.94e-05 | 3 | 89 | 2 | 23917429 | |
| Pubmed | Identification of p130cas as an in vivo substrate of receptor protein-tyrosine phosphatase alpha. | 1.94e-05 | 3 | 89 | 2 | 10787408 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 18281286 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 28533432 | ||
| Pubmed | SMAP, an Smg GDS-associating protein having arm repeats and phosphorylated by Src tyrosine kinase. | 1.94e-05 | 3 | 89 | 2 | 8900189 | |
| Pubmed | Beyond Epilepsy and Autism: Disruption of GABRB3 Causes Ocular Hypopigmentation. | 1.94e-05 | 3 | 89 | 2 | 28009282 | |
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 12615930 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 12826681 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 19497848 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 20385765 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 12598528 | ||
| Pubmed | 1.94e-05 | 3 | 89 | 2 | 19812040 | ||
| Pubmed | 2.08e-05 | 21 | 89 | 3 | 25708312 | ||
| Pubmed | 2.55e-05 | 225 | 89 | 6 | 12168954 | ||
| Pubmed | NOP58 PTPRA CYP3A5 UBE3A OTUD5 NACC1 NR5A2 PHF14 ELF2 CHD8 SLC25A28 TTK NDUFS2 | 3.25e-05 | 1327 | 89 | 13 | 32694731 | |
| Pubmed | Genome-wide association of lipid-lowering response to statins in combined study populations. | 3.61e-05 | 72 | 89 | 4 | 20339536 | |
| Pubmed | 3.83e-05 | 638 | 89 | 9 | 31182584 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 24587194 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 11902122 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 7518772 | ||
| Pubmed | Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase. | 3.87e-05 | 4 | 89 | 2 | 9261115 | |
| Pubmed | A novel ATPase on mouse chromosome 7 is a candidate gene for increased body fat. | 3.87e-05 | 4 | 89 | 2 | 11074018 | |
| Pubmed | Differential assembly diversifies GABAA receptor structures and signalling. | 3.87e-05 | 4 | 89 | 2 | 35355020 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 25489750 | ||
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 18211905 | ||
| Pubmed | GABAA Receptors and the Diversity in their Structure and Pharmacology. | 3.87e-05 | 4 | 89 | 2 | 28528665 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 20055753 | ||
| Pubmed | Activation of Src and transformation by an RPTPα splice mutant found in human tumours. | 3.87e-05 | 4 | 89 | 2 | 21725282 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 10767340 | ||
| Pubmed | Mechanistic insights of NAC1 nuclear export and its role in ovarian cancer resistance to docetaxel. | 3.87e-05 | 4 | 89 | 2 | 37019189 | |
| Pubmed | 3.87e-05 | 4 | 89 | 2 | 11923305 | ||
| Pubmed | NAC1 regulates the recruitment of the proteasome complex into dendritic spines. | 6.44e-05 | 5 | 89 | 2 | 17699672 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 7643102 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 9440711 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 18596232 | ||
| Pubmed | Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase. | 6.44e-05 | 5 | 89 | 2 | 22632832 | |
| Pubmed | Fine mapping of Ath6, a quantitative trait locus for atherosclerosis in mice. | 6.44e-05 | 5 | 89 | 2 | 11420610 | |
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 27129275 | ||
| Pubmed | 6.44e-05 | 5 | 89 | 2 | 12595241 | ||
| Pubmed | Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit. | 6.44e-05 | 5 | 89 | 2 | 9039914 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 3.41e-05 | 19 | 61 | 3 | 563 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 6.13e-04 | 115 | 61 | 4 | 769 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.26e-03 | 21 | 61 | 2 | 813 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KIFAP3 SNX4 PTPRA STAG1 UBE3A XPO6 PKP4 SYNE2 DDX42 USP24 CHD9 PHF14 PPIP5K2 TTK ADGRA3 | 1.34e-07 | 856 | 87 | 15 | M4500 |
| Coexpression | GSE13229_IMM_VS_INTMATURE_NKCELL_DN | 4.73e-06 | 200 | 87 | 7 | M3212 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | COQ10A CREBRF IRGM GLTP PTPRE GPR37 CNIH2 PKP4 PCNX1 PIGG EFCAB7 KDM6A CERS4 MGME1 | 1.53e-05 | 1102 | 87 | 14 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | COQ10A CREBRF IRGM GLTP PTPRE GPR37 CNIH2 PKP4 PCNX1 PIGG EFCAB7 KDM6A CERS4 MGME1 | 1.91e-05 | 1124 | 87 | 14 | MM1070 |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | 5.09e-05 | 197 | 87 | 6 | M8271 | |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_UP | 5.53e-05 | 200 | 87 | 6 | M4817 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_12H_BMDC_DN | 5.53e-05 | 200 | 87 | 6 | M3722 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.34e-06 | 156 | 86 | 7 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.29e-05 | 127 | 86 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.45e-05 | 151 | 86 | 6 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.15e-05 | 230 | 86 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 4.66e-05 | 97 | 86 | 5 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | GABRB1 GABRB2 KIFAP3 UBE3A PKP4 SYNE2 DDX42 SRP54 CHD9 CHD8 CALCRL KDM6A | 7.90e-05 | 790 | 86 | 12 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | GABRB1 CREBRF UBE3A GPR37 PKP4 SYNE2 CHD9 CHD8 CALCRL TEX11 KDM6A CERS4 | 8.39e-05 | 795 | 86 | 12 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.27e-04 | 275 | 86 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 1.41e-04 | 65 | 86 | 4 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.12e-04 | 210 | 86 | 6 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.46e-04 | 138 | 86 | 5 | gudmap_developingGonad_e12.5_epididymis_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | GABRB1 KIFAP3 UBE3A PKP4 SYNE2 NR5A2 CHD8 CALCRL TEX11 KDM6A CERS4 | 2.98e-04 | 778 | 86 | 11 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | BM Top 100 - heart atrium | 2.99e-04 | 79 | 86 | 4 | BM Top 100 - heart atrium | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.07e-04 | 225 | 86 | 6 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.39e-04 | 323 | 86 | 7 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.45e-04 | 82 | 86 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | 3.71e-04 | 433 | 86 | 8 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | GABRB1 KIFAP3 UBE3A GPR37 PKP4 SYNE2 CHD9 CHD8 CALCRL PPIP5K2 KDM6A | 3.94e-04 | 804 | 86 | 11 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | KIFAP3 PTPRE KCNH1 GPR37 PKP4 SYNE2 NR5A2 CHD9 CHD8 TEX11 KDM6A | 4.02e-04 | 806 | 86 | 11 | gudmap_developingGonad_e12.5_epididymis_1000 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-09 | 196 | 88 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 6.28e-09 | 200 | 88 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 195 | 88 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-07 | 198 | 88 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-07 | 198 | 88 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-07 | 198 | 88 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.45e-07 | 200 | 88 | 7 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.45e-07 | 200 | 88 | 7 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 1.45e-07 | 200 | 88 | 7 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-06 | 176 | 88 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 178 | 88 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.77e-06 | 184 | 88 | 6 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.00e-06 | 188 | 88 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.07e-06 | 189 | 88 | 6 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-06 | 191 | 88 | 6 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.70e-06 | 198 | 88 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 2.86e-06 | 200 | 88 | 6 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | Endothelial-F|World / shred on cell class and cell subclass (v4) | 8.35e-06 | 139 | 88 | 5 | 32d3c5d35e6c4205711c3500d736fd108443e6b4 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-05 | 161 | 88 | 5 | 8de421c61f4d5a6e05fdb20e4d230e2db98ee4d5 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.75e-05 | 162 | 88 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 175 | 88 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.61e-05 | 176 | 88 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.75e-05 | 178 | 88 | 5 | 0139b42494c1186390b12106dea7957e2b6717c2 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-05 | 180 | 88 | 5 | 6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.98e-05 | 181 | 88 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-05 | 184 | 88 | 5 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.31e-05 | 185 | 88 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-lymphatic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.40e-05 | 186 | 88 | 5 | 86b218a400f9c64f92b050f00b49f09647b17437 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.40e-05 | 186 | 88 | 5 | f51c76b1c3c6c49e0ebc9a913d8413e0b6a04d80 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 188 | 88 | 5 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-05 | 188 | 88 | 5 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.57e-05 | 188 | 88 | 5 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 188 | 88 | 5 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 188 | 88 | 5 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 188 | 88 | 5 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 188 | 88 | 5 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-05 | 190 | 88 | 5 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.85e-05 | 191 | 88 | 5 | 6e1d00404d795ec7cf60f685e42e4ad9a16ac596 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.85e-05 | 191 | 88 | 5 | f158e393976b685b896a41871bda1ab65a8b58f5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 191 | 88 | 5 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 3.95e-05 | 192 | 88 | 5 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.95e-05 | 192 | 88 | 5 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 193 | 88 | 5 | 3e3d7cb3e7242ec9c9677e07e303835649852b52 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.05e-05 | 193 | 88 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-05 | 194 | 88 | 5 | badefcec2af86cbcd97305f4843e84db0f3ebc66 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.25e-05 | 195 | 88 | 5 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-05 | 195 | 88 | 5 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.25e-05 | 195 | 88 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-05 | 196 | 88 | 5 | 291c59b609985167c98a40d4e2caeea2fad74941 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-05 | 197 | 88 | 5 | 0523aec9713ae21e6b879aa98e07fa2576610d5f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-05 | 197 | 88 | 5 | 57dafb3047745a44b2345b8036e159c3641d496e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.46e-05 | 197 | 88 | 5 | 826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-05 | 198 | 88 | 5 | 96883ad8e189a46ed5b7eaafc0543e53682d26ed | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.57e-05 | 198 | 88 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.57e-05 | 198 | 88 | 5 | 623f9d64c9e800d2d7f623392bf2f22b563f0249 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.68e-05 | 199 | 88 | 5 | 04adf46975aa4194ea40c7480f8a517def5d929c | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.68e-05 | 199 | 88 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.68e-05 | 199 | 88 | 5 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Stem_cells-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 4.79e-05 | 200 | 88 | 5 | c00cc0b91baa37828895d9d6b8acbc6aa503215a | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Stem_cells|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 4.79e-05 | 200 | 88 | 5 | 9e1b62a703fb7d413ce580448a1df5127c28e8a7 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.79e-05 | 200 | 88 | 5 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | LV-03._Atrial_Cardiomyocyte|LV / Chamber and Cluster_Paper | 9.44e-05 | 120 | 88 | 4 | 3b77bd0e3630cdd45001cecf5e47660a90ebc92e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 9.75e-05 | 121 | 88 | 4 | 19333a660800b583fa27b495c1f7828e6636a257 | |
| ToppCell | Control-PLT_5|World / Disease Group and Platelet Clusters | 1.14e-04 | 126 | 88 | 4 | 4ba753c4e83eb1d41964edfa22135e047f06c481 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 1.49e-04 | 135 | 88 | 4 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.53e-04 | 136 | 88 | 4 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.53e-04 | 136 | 88 | 4 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 1.71e-04 | 140 | 88 | 4 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 142 | 88 | 4 | b66f9602dba30d1d4fbcc49ceb112eb5bd916ba1 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.06e-04 | 147 | 88 | 4 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-3|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-04 | 153 | 88 | 4 | 9d64aadbb4bb28469af1d728457b431e21577429 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.59e-04 | 156 | 88 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 157 | 88 | 4 | 8d30d8e6fae93afcada6bd68799439335cd65b69 | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 157 | 88 | 4 | 2ac4695d9e4ca8d4ba19c555e9a1d86ac8f398ab | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-04 | 157 | 88 | 4 | 8a393eece90fb9a1b7c356736bdb36277261fbd3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-04 | 161 | 88 | 4 | fb59d96c2aa9e4654f02bf6ce36bf832776cb4dd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-04 | 161 | 88 | 4 | c53c461fc721a7960cef86662f49e2a495520701 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.92e-04 | 161 | 88 | 4 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.98e-04 | 162 | 88 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-04 | 162 | 88 | 4 | 2ac02523348660e514d464f8f2434ee0c312d784 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.98e-04 | 162 | 88 | 4 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.27e-04 | 166 | 88 | 4 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | BAL-Severe-cDC_5|Severe / Compartment, Disease Groups and Clusters | 3.43e-04 | 168 | 88 | 4 | 857a80c217a5513553460798a625612031bc7bb7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.43e-04 | 168 | 88 | 4 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.43e-04 | 168 | 88 | 4 | c3d2d573f21350a4a674faff30b06ff644d00ac3 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-04 | 169 | 88 | 4 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.58e-04 | 170 | 88 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.58e-04 | 170 | 88 | 4 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-04 | 170 | 88 | 4 | cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.58e-04 | 170 | 88 | 4 | 46a81d505de845cc59f80594fce338f7fdb9250f | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.58e-04 | 170 | 88 | 4 | 1a9a0487c35cf3fd5806d1f0f0e91ef0e0b9cd0a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-04 | 170 | 88 | 4 | da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017 | |
| Computational | Neurotransmitter (GABA) receptor. | 4.66e-05 | 15 | 52 | 3 | MODULE_215 | |
| Drug | Adinazolam | 3.19e-06 | 8 | 89 | 3 | DB00546 | |
| Drug | Fludiazepam | 3.19e-06 | 8 | 89 | 3 | DB01567 | |
| Drug | Clotiazepam | 3.19e-06 | 8 | 89 | 3 | DB01559 | |
| Drug | Cinolazepam | 3.19e-06 | 8 | 89 | 3 | DB01594 | |
| Drug | Prazepam | 3.19e-06 | 8 | 89 | 3 | DB01588 | |
| Drug | Estazolam | 3.19e-06 | 8 | 89 | 3 | DB01215 | |
| Drug | Halazepam | 3.19e-06 | 8 | 89 | 3 | DB00801 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 3.19e-06 | 8 | 89 | 3 | ctd:C091518 | |
| Drug | Ethchlorvynol | 4.77e-06 | 9 | 89 | 3 | DB00189 | |
| Drug | Diazepam | 4.77e-06 | 9 | 89 | 3 | DB00829 | |
| Drug | 3-isothujone | 5.53e-06 | 30 | 89 | 4 | CID000011027 | |
| Drug | Chlordiazepoxide | 6.79e-06 | 10 | 89 | 3 | DB00475 | |
| Drug | Clobazam | 6.79e-06 | 10 | 89 | 3 | DB00349 | |
| Drug | Bromazepam | 6.79e-06 | 10 | 89 | 3 | DB01558 | |
| Drug | Oxazepam | 6.79e-06 | 10 | 89 | 3 | DB00842 | |
| Drug | Midazolam | 6.79e-06 | 10 | 89 | 3 | DB00683 | |
| Drug | Flurazepam | 6.79e-06 | 10 | 89 | 3 | DB00690 | |
| Drug | Clonazepam | 6.79e-06 | 10 | 89 | 3 | DB01068 | |
| Drug | acetophenone | 7.21e-06 | 32 | 89 | 4 | CID000007410 | |
| Drug | Alprazolam | 9.31e-06 | 11 | 89 | 3 | DB00404 | |
| Drug | Temazepam | 9.31e-06 | 11 | 89 | 3 | DB00231 | |
| Drug | Nitrazepam | 9.31e-06 | 11 | 89 | 3 | DB01595 | |
| Drug | Lorazepam | 9.31e-06 | 11 | 89 | 3 | DB00186 | |
| Drug | Triazolam | 9.31e-06 | 11 | 89 | 3 | DB00897 | |
| Drug | Clorazepate | 9.31e-06 | 11 | 89 | 3 | DB00628 | |
| Drug | Etomidate | 9.31e-06 | 11 | 89 | 3 | ctd:D005045 | |
| Drug | secobarbital | 1.31e-05 | 37 | 89 | 4 | CID000005193 | |
| Drug | I5B1 | 1.31e-05 | 37 | 89 | 4 | CID005487705 | |
| Drug | phaclofen | 1.51e-05 | 2 | 89 | 2 | ctd:C052329 | |
| Drug | pentobarbital | 2.82e-05 | 224 | 89 | 7 | CID000004737 | |
| Drug | lindane | 3.18e-05 | 154 | 89 | 6 | CID000000727 | |
| Drug | zolpidem | 3.77e-05 | 17 | 89 | 3 | ctd:C049109 | |
| Drug | dihydroxyaflavinine | 3.77e-05 | 17 | 89 | 3 | CID000156857 | |
| Drug | Muscimol | 5.35e-05 | 19 | 89 | 3 | ctd:D009118 | |
| Drug | triazolam | 5.94e-05 | 54 | 89 | 4 | CID000005556 | |
| Drug | endrine | 6.05e-05 | 106 | 89 | 5 | CID000003048 | |
| Drug | delta-hexachlorocyclohexane | 6.27e-05 | 20 | 89 | 3 | ctd:C086916 | |
| Drug | cisapride | 7.87e-05 | 112 | 89 | 5 | CID000002769 | |
| Drug | flunitrazepam | 8.42e-05 | 59 | 89 | 4 | CID000003380 | |
| Drug | AC1Q3G0K | 9.00e-05 | 60 | 89 | 4 | CID000002087 | |
| Drug | 2,6-diisopropyl-4-(3-(3-methyl-3H-diazirin-3-yl)propyl)phenol | 9.02e-05 | 4 | 89 | 2 | ctd:C570407 | |
| Drug | Propofol | 9.02e-05 | 4 | 89 | 2 | DB00818 | |
| Drug | loreclezole | 9.02e-05 | 4 | 89 | 2 | ctd:C066440 | |
| Drug | Fospropofol | 9.02e-05 | 4 | 89 | 2 | DB06716 | |
| Drug | pf26 | 9.02e-05 | 4 | 89 | 2 | CID000032197 | |
| Drug | pentanol | 9.66e-05 | 23 | 89 | 3 | CID000006276 | |
| Drug | diazepam | 9.92e-05 | 189 | 89 | 6 | CID000003016 | |
| Drug | methohexital | 1.10e-04 | 24 | 89 | 3 | CID000009034 | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.11e-04 | 193 | 89 | 6 | 6205_DN | |
| Drug | Austricine [10180-88-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.24e-04 | 197 | 89 | 6 | 2812_DN | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.32e-04 | 199 | 89 | 6 | 3615_UP | |
| Drug | enflurane | 1.47e-04 | 68 | 89 | 4 | CID000003226 | |
| Drug | hexane | 1.47e-04 | 68 | 89 | 4 | CID000008058 | |
| Drug | alphaxalone | 1.50e-04 | 5 | 89 | 2 | ctd:C006477 | |
| Drug | Advicor | 1.50e-04 | 5 | 89 | 2 | CID000151176 | |
| Drug | tert-butylbicyclophosphorothionate | 1.50e-04 | 5 | 89 | 2 | ctd:C037476 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.47e-07 | 152 | 87 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 8.59e-07 | 7 | 87 | 3 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Epilepsy | 8.76e-07 | 109 | 87 | 6 | C0014544 | |
| Disease | Epilepsy, Cryptogenic | 4.53e-06 | 82 | 87 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 4.53e-06 | 82 | 87 | 5 | C0751111 | |
| Disease | Aura | 4.53e-06 | 82 | 87 | 5 | C0236018 | |
| Disease | Neurodevelopmental Disorders | 8.41e-06 | 93 | 87 | 5 | C1535926 | |
| Disease | N-stearoyl-sphingosine (d18:1/18:0) measurement | 2.57e-05 | 3 | 87 | 2 | EFO_0800613 | |
| Disease | proprotein convertase subtilisin/kexin type 9 measurement | 3.66e-05 | 22 | 87 | 3 | EFO_0009312 | |
| Disease | Angelman Syndrome | 5.14e-05 | 4 | 87 | 2 | C0162635 | |
| Disease | congenital heart disease (implicated_via_orthology) | 5.27e-05 | 69 | 87 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | Sphingomyelin (d18:1/20:0, d16:1/22:0) measurement | 8.54e-05 | 5 | 87 | 2 | EFO_0022109 | |
| Disease | hearing threshold measurement, pure tone hearing measurement | 8.54e-05 | 5 | 87 | 2 | EFO_0007617, EFO_0007618 | |
| Disease | level of Sphingomyelin (d38:1) in blood serum | 9.49e-05 | 30 | 87 | 3 | OBA_2045180 | |
| Disease | vasoactive peptide measurement | 1.28e-04 | 6 | 87 | 2 | EFO_0005196 | |
| Disease | stearoyl sphingomyelin (d18:1/18:0) measurement | 1.28e-04 | 6 | 87 | 2 | EFO_0800611 | |
| Disease | Primary dilated cardiomyopathy | 1.39e-04 | 34 | 87 | 3 | cv:C0007193 | |
| Disease | glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement | 1.79e-04 | 7 | 87 | 2 | EFO_0800551 | |
| Disease | QRS-T angle | 2.78e-04 | 106 | 87 | 4 | EFO_0020097 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 2.81e-04 | 43 | 87 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | Familial dilated cardiomyopathy | 3.00e-04 | 44 | 87 | 3 | C0340427 | |
| Disease | level of Sphingomyelin (d36:1) in blood serum | 3.05e-04 | 9 | 87 | 2 | OBA_2045178 | |
| Disease | Neuroblastoma | 3.65e-04 | 47 | 87 | 3 | C0027819 | |
| Disease | Cardiomyopathy | 3.65e-04 | 47 | 87 | 3 | cv:C0878544 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 4.14e-04 | 49 | 87 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Cardiomyopathies | 6.03e-04 | 130 | 87 | 4 | C0878544 | |
| Disease | ceramide measurement | 6.67e-04 | 235 | 87 | 5 | EFO_0010222 | |
| Disease | urate measurement, spine bone mineral density | 6.79e-04 | 58 | 87 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Autistic Disorder | 1.07e-03 | 261 | 87 | 5 | C0004352 | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 1.14e-03 | 17 | 87 | 2 | OBA_2045173 | |
| Disease | Cardiomegaly | 1.85e-03 | 82 | 87 | 3 | C0018800 | |
| Disease | Cardiac Hypertrophy | 1.85e-03 | 82 | 87 | 3 | C1383860 | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 1.91e-03 | 22 | 87 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | Dyslipidemias | 2.27e-03 | 24 | 87 | 2 | C0242339 | |
| Disease | Dyslipoproteinemias | 2.27e-03 | 24 | 87 | 2 | C0598784 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 2.67e-03 | 26 | 87 | 2 | DOID:234 (is_implicated_in) | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 2.67e-03 | 26 | 87 | 2 | OBA_2045191 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 2.68e-03 | 195 | 87 | 4 | DOID:1574 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MEQFGQQQYDIYERM | 361 | Q99569 | |
| MNAEVYYMHEDILQN | 366 | P60509 | |
| GSLASRQMIQQYEMY | 891 | Q9HCK8 | |
| MVNYMQYQQVCDALF | 251 | Q9HA82 | |
| NYVCLQERYMTEMQQ | 416 | Q8TC20 | |
| TVMYRNYQRKNDMDE | 536 | Q8TDI0 | |
| MEQAQAYVMRYFESS | 571 | P33076 | |
| TYDAVVQMEYLDMVV | 346 | P20815 | |
| FMYELDREMNYQQNP | 41 | Q8IUR6 | |
| YANDVTRVLYMFNQM | 416 | Q8IWK6 | |
| KSEESYMVQDYAQMN | 541 | Q5VV41 | |
| YMVQDYAQMNHIQVE | 546 | Q5VV41 | |
| RHEGDMYNMQYSSQQ | 1456 | Q8NFD5 | |
| MGANQLVVLNVYDMY | 1 | Q9BSY9 | |
| IKMQVYFDMNYTNRV | 81 | Q8IYR0 | |
| AAQAMVQYYQEKSAV | 566 | Q5T481 | |
| EYRTQLYEYLQNRMM | 266 | Q9Y2X3 | |
| NEVNNEMANRMSLFY | 176 | Q9H0Q0 | |
| QMVQTDMQYTFIYQA | 376 | P23469 | |
| QNSQYQDMVASVMYT | 271 | Q8NGR6 | |
| DYTSQRFYMMQGIVI | 121 | Q4G0Z9 | |
| QVVAYMGAMNHDTNY | 271 | Q9BQP7 | |
| LENYLMEMQFNRYDF | 101 | A1A4Y4 | |
| EQYKMEDLMQVYDQF | 1376 | O15550 | |
| FQQMYANTNRYHEML | 471 | Q8NCM2 | |
| MDRGNNNVMSNYEAY | 671 | Q86XP3 | |
| LEYNQYEVRNAATMM | 1331 | Q96RV3 | |
| AEVVKQRMQMYNSPY | 191 | Q96A46 | |
| IFQQMYANTNRYHEM | 501 | O95259 | |
| MGTINQQAMDQLYYV | 131 | Q9H0R5 | |
| SEVNMDYTLTMYFQQ | 76 | P18505 | |
| EVNMDYTLTMYFQQA | 76 | P47870 | |
| SEVNMDYTLTMYFQQ | 76 | P28472 | |
| QTMDRLYFVMEYVNG | 411 | P05771 | |
| NMVLCLMNQTYREEY | 116 | Q9BZM2 | |
| NYYFERNMRMIQIQE | 621 | O94880 | |
| YVSMMCNEQAYSLAV | 141 | O75306 | |
| AYLTNEYMQRMASVR | 376 | Q9H361 | |
| MRRMICLNDEAYNNY | 561 | Q6ZMV5 | |
| DRMYQMDIQQELQRY | 2521 | P04114 | |
| SLISRQMIQQYEMYF | 941 | Q3L8U1 | |
| QMIQQYEMYFRDSQG | 946 | Q3L8U1 | |
| RAATNVQMYYEMIEN | 361 | O15354 | |
| MEASYYDNIMEQQRL | 1336 | Q8IZD9 | |
| NEIVQYGRNMSSMAY | 591 | Q9UBT7 | |
| QYRMQIAQRSMVYLT | 291 | A8K855 | |
| RQMIQQYEMVYRDAQ | 546 | Q8TD26 | |
| YYEIQNNDIRMEMAF | 746 | Q5T0N1 | |
| DILMYMDRVYVQQNN | 121 | Q13618 | |
| SMQEMYEVVSNVQEY | 96 | Q96MF6 | |
| MMEYRHQIQSYTCEI | 321 | P17661 | |
| QFNTMYMYRHENVSI | 306 | O60266 | |
| AQVLVYDDETYMMQD | 51 | Q15723 | |
| IDVIYEMYTQMNAEL | 191 | Q9NZD2 | |
| VASMYTPNAQYCQMR | 36 | P03952 | |
| IMTAQYECYQKIMQD | 41 | Q16602 | |
| RQIQFEIAHAYYDMM | 471 | Q96EK5 | |
| MVESRQMDESEQYLY | 686 | Q92845 | |
| QAMAEMYNRPVEVYQ | 286 | Q96G74 | |
| RCQMVQTDMQYVFIY | 481 | P18433 | |
| MQVSQFKMVNYSYDE | 66 | O00482 | |
| NFNYEYAQMEVTMKA | 586 | Q9NQT8 | |
| RNAMNMQETYTAYLI | 71 | O95219 | |
| AQIASGMAYVERMNY | 371 | P12931 | |
| QFTLRDMYEQFQNIM | 326 | P61011 | |
| VKIADVEMQYYINVM | 346 | Q8NHS9 | |
| IYDQLYDEVNMMTIR | 5281 | Q8WXH0 | |
| MYDAVSIMNADILNY | 116 | Q6PI25 | |
| YMSNEKIAQEEYMFQ | 471 | Q8WXI2 | |
| IEQNLTNYYEMMLTD | 411 | Q9UNS1 | |
| RIYEEMNNMSSAAEY | 326 | Q8TAM2 | |
| LYRNVMMETYGNVVS | 46 | P15622 | |
| YNADQIRRMMETFQQ | 331 | Q05086 | |
| ILNIYRYMVVQVSMD | 561 | Q6GYQ0 | |
| NYMQELMENAVFTFE | 441 | Q9BZQ8 | |
| VQKTLYQEVMMENYD | 26 | Q96SK3 | |
| YQEVMMENYDNLVSL | 31 | Q96SK3 | |
| SYETQMNMLYSQLVE | 906 | Q8IYF3 | |
| IRQCQYSIIYDEYMM | 186 | Q8WVM7 | |
| ATCYMNSVIQQLYMI | 1566 | O00507 | |
| NINSMHNREYYMAEV | 556 | Q5HYM0 | |
| ATCYMNAVFQQLYMQ | 1696 | Q9UPU5 | |
| QYIYMVMECGNIDLN | 596 | P33981 | |
| NELNYMTQIVIMLYE | 861 | O43314 | |
| RNDYVMMYSLTVFEN | 56 | Q96QU8 | |
| QVAQYDIYSMMVGTV | 426 | Q5H8A4 | |
| MNTEEAANTMVNYYT | 101 | P26599 | |
| YMTQIVIMLYEDNTQ | 881 | Q6PFW1 | |
| YTMENIMEVIRNQEF | 336 | Q9NR64 | |
| EGMDEQYRQICNMYT | 291 | Q96RE7 | |
| YMDMYRRNQALEQEL | 511 | O15049 | |
| VYEMRVYAVNAIGMS | 841 | Q14896 |